These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3922382)

  • 41. [Treatment of ureteral colic with glycerol trinitrate].
    Hofstetter AG; Kriegmair M
    Fortschr Med; 1993 Jun; 111(16):286-8. PubMed ID: 8330828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma nitroglycerin levels, blood pressure and apical heart rate variations to site of application of nitroglycerin ointment.
    Conant CC
    Nurse Pract; 1988 Oct; 13(10):56, 58, 63-4. PubMed ID: 3147433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitroglycerin-patch induced tolerance is associated with reduced ability of nitroglycerin to increase exhaled nitric oxide.
    Agvald P; Hammar L; Gustafsson LE
    Vascul Pharmacol; 2005 Dec; 43(6):449-57. PubMed ID: 16230051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The bioavailability of transdermal therapeutic system of timolol].
    Ji XF; Ping QN; Liu GJ; Yu ST
    Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population pharmacokinetics of nitroglycerin and of its two metabolites after a single 24-hour application of a nitroglycerin transdermal matrix delivery system.
    Auclair B; Sirois G; Ngoc AH; Ducharme MP
    Ther Drug Monit; 1998 Dec; 20(6):607-11. PubMed ID: 9853974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamic and pharmacokinetic evaluation of a new transdermal delivery system with a time-dependent release of glyceryl trinitrate.
    Wiegand A; Bauer KH; Bonn R; Trenk D; Jähnchen E
    J Clin Pharmacol; 1992 Jan; 32(1):77-84. PubMed ID: 1740541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of a new transdermal nitroglycerin adhesive patch formulation.
    Riedel DJ; Wick KA; Hawkinson RW; Kolars CA; Crowley JK; Armstrong KE; Chang SF; Harrison LI; de Dennis SR
    Clin Ther; 1989; 11(2):225-31. PubMed ID: 2500248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transdermal nitroglycerin systems: methods for comparison.
    Harrison LI; Riedel DJ
    Clin Ther; 1991; 13(3):361-7. PubMed ID: 1954637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of low dose of dipyridamole on glyceryl trinitrate tolerance in healthy volunteers.
    Torfgård KE; Ahlner J
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):516-21. PubMed ID: 7681894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Principles of transdermal nitroglycerin administration.
    Wolff HM; Bonn R
    Eur Heart J; 1989 May; 10 Suppl A():26-9. PubMed ID: 2501091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exposure to glyceryl trinitrate during gun powder production: plasma glyceryl trinitrate concentration, elimination kinetics, and discomfort among production workers.
    Gjesdal K; Bille S; Bredesen JE; Bjørge E; Halvorsen B; Langseth K; Lunde PK; Silvertssen E
    Br J Ind Med; 1985 Jan; 42(1):27-31. PubMed ID: 3917307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative bioavailability of a new transdermal nitroglycerin delivery system.
    Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A
    J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of glyceryl trinitrate in human plasma by gas chromatography--negative ion chemical ionization--selected ion monitoring.
    Idzu G; Ishibashi M; Miyazaki H; Yamamoto K
    J Chromatogr; 1982 May; 229(2):327-36. PubMed ID: 6807999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simultaneous determination of glyceryl trinitrate and its principal metabolites, 1,2- and 1,3-glyceryl dinitrate, in plasma by gas chromatography-negative ion chemical ionization-selected ion monitoring.
    Miyazaki H; Ishibashi M; Hashimoto Y; Idzu G; Furuta Y
    J Chromatogr; 1982 Apr; 239():277-86. PubMed ID: 6808000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel pharmacokinetic modelling of transdermal nitroglycerin.
    Auclair B; Sirois G; Ngoc AH; Ducharme MP
    Pharm Res; 1998 Apr; 15(4):614-9. PubMed ID: 9587959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemodynamic effects of glyceryl trinitrate following repeated application of a transdermal delivery system with a phasic release profile.
    Wiegand A; Bonn R; Wagner F; Trenk D; Jähnchen E
    Eur J Clin Pharmacol; 1991; 41(2):115-8. PubMed ID: 1743242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human pharmacological studies of a new transdermal system containing nitroglycerin.
    Müller P; Imhof PR; Burkart F; Chu LC; Gérardin A
    Eur J Clin Pharmacol; 1982; 22(6):473-80. PubMed ID: 6813125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human maternal and fetal plasma glyceryl trinitrate concentrations.
    Bustard MA; Ryan G; Seaward G; Saleniak ME; Smith GN
    Am J Obstet Gynecol; 2003 Dec; 189(6):1777-8. PubMed ID: 14710114
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.